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The DNA sequence of the Bacillus subtilis sdh operon coding for the two succinate dehydrogenase subunits 
and cytochrome b-558 (the membrane anchor protein) has recently been established. We have now deter- 
mined the extent of N-terminal processing of each polypeptide by radiosequence analysis. At the same time, 
direct evidence for the correctness of the predicted reading frames has been obtained. The cytochrome 
showed a ragged N-terminus, with forms lacking one residue, and is inserted across the membrane without 
an N-terminal leader-peptide. Covalently bound flavin was not detectable in B. subtilis succinate dehydroge- 
nase expressed in Escherichia coli despite normal N-terminal processing of the apoprotein. This provides 
an explanation to why the succinate dehydrogenase synthesized in E. coli is not functional and demonstrates 
that host-specific factors regulate the coenzyme attachment. 
Succinate dehydrogenase; Post-translational processing; Heterologous ystem: Electroblotting; Radiosequence analysis; 
N-terminal heterogeneity 
1. INTRODUCTION 
Succinate dehydrogenase (SDH) (EC 1.3.99.1) 
consists of two protein subunits, a larger flavopro- 
tein (Fp) with one 8cr-N(3)His-bound FAD, and a 
smaller iron-sulfur protein (Ip) containing three 
different iron-sulfur centers [1,2]. It is not known 
by what mechanism(s) flavin becomes covalently 
bound to this or other proteins [3-51. 
Bacillus subtilis SDH can be solubilized from the 
cytoplasmic membrane as a complex consisting of 
equimolar amounts of Fp (65 kDa), Ip (28 kDa) 
and cytochrome b-558 (23 kDa) [6]. The 
cytochrome spans the lipid bilayer and anchors 
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SDH to the inner surface of the cytoplasmic mem- 
brane [7]. The nucleotide sequence of the genes 
coding for Fp, Ip, and cytochrome b-558 was 
recently determined from the cloned B. subtilis 
sdhCAB operon [8,9]. To confirm each of the 
reading frames predicted from the DNA sequence 
and to determine possible N-terminal post- 
translational processings of the subunits, we have 
studied the proteins by radiosequence analysis. 
The cytochrome was of particular interest, since it 
could be synthesized as a larger precursor with an 
N-terminal leader peptide, similar to those which 
have been found in other proteins that are 
transported across membranes [lo]. 
All three polypeptides of the B. subtilis 
SDH-cytochrome b-558 complex are expressed in 
Escherichia coli from the sdhCAB operon cloned 
in plasmid vectors [9,11,12]. However, the 
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heterologous enzyme complex is not assembled on 
the membrane. We show here that B. ~~~~~~~~ Fp 
synthesized from the intact sdhA gene in E. co& 
does not contain covalently bound flavin. This 
finding suggests a structural difference in apo-Fp 
synthesized in the two bacteria or an absence in E. 
coli of special factors required for flavinylation of 
B. subtilis SDH. 
2. MATERIALS AND METHODS 
B. subtiiis BR95 (trpC2 i&Cl pheilf) ws grown 
in minimal medium 163 with 1% (w/v) sodium suc- 
cinate as a source of carbon and energy. The 
medium was supplemented with 0.12% (w/v) 
amino acids (casamino acids, Difco), 10 PM 
MnClz, 4 mCi/l L-[2,3,4,5,6-3H]Phe (0.13 Ci/ 
mol, Amersham), 20 mg/l L-Trp, 20 mg/l L-Ile 
and 20 mg/l L-Val. B. subtilis KA97123 (trpC2 
fez4-2 scJhB123) was grown in nutrient sporulation 
medium 161, pH 7, without added M&l2 and 
containing 2 mCi/l f3%]Met (1.42 Ciimol, 
Amersham). E. cofi MVl~h3/8& (0500 
AtrpE.5 : : ChY86) ~ont~ning plasmid pSHiO47 
which carries the cloned B. subtifis sdhCA3 
operon 19,131 was grown in nutrient sporulation 
medium, pH 7, supplemented with 0.5% (w/v) 
glucose, 20 mg/l thiamine, 40 mg/l nicotinic acid, 
20 mg/l L-Trp, SO mg/l kanamycin (Sigma) and 
2.2 mCi/l 13’S]Met. The bacteria, in about 300 ml 
medium, were grown at 37°C in 2.8 1 indentated 
Fernbach flasks on a rotary shaker (200 rpm) and 
were harvested in the late exponential growth 
phase. B. ~~~~~~~ membranes and protoplasts were 
prepared as described [6] _ E. coii spheroplasts were 
prepared in 20% (w/v) sucrose, 30 mhil Tris-HCl, 
pH 8, as described 1141. 
2.2. Isolation of subunits 
Antibodies against he B. subtilis Fp subunit [15] 
were used for test-tube precipitation [161 of 
solubilized SDH-cytochrome b-558 complex from 
13H]Phe-labelled B. subtifis BR95 membranes and 
of soluble Fp from [3sS]Met-labe11ed cells. The 
soluble cell fractions were prepared from pro- 
toplasts of B. subfifis KA97123 and from 
spheroplasts of E. coil MVI~h3~86(pSHI~7)_ 
The protoplasts/spheroplasts from 225-250 ml 
cultures (A~oo =0.7) were collected by centrifuga- 
tion (7000 x g, 20 min, WC) and were lysed in 
1.5 ml cold 30 mM Tris-HCl, pH 8.0, containing 
10 mM Na-EDTA, 2 mM phenylmethylsulfonyl 
fluoride, 2 mM benzamidine-HCI, and 5 mg/l 
each of chymostatin, leupeptin, elastatinal and an- 
tipain (Sigma). The cell lysates were gently 
sonicated and centrifuged (45000 x g, 30 min, 
4°C). The supernatant was centrifuged (100000 x 
g, 1 h, 4°C) to produce the soluble ceil fraction. 
Liquid-phase amino acid sequence analysis of 
immunoprecipitates was performed with a 
Beckman 8WD sequencer. Gas-phase sequencer 
degradations were carried out in an Applied 
Biosystems 470A instrument with polypeptides 
separately electroblotted from SDS poly- 
acrylamide gels directly onto polybrene-coated 
glass-fiber filter discs [17]. Before sequencer ap- 
plications, apomyoglobin was added as carrier and 
standard. Phenylthiohydantoin derivatives from 
degradations of the myoglobin were identified in 
aliquots by reverse-phase high-performance liquid 
chromatography {la], the remaining parts being 
used for determinations of radioactivity by liquid 
scintillation counting. Protein was determined by 
the procedure of Lowry et al. 1191 in the presence 
of 1.7010 (w/v) SDS and with serum albumin as 
standard. Fluorimetric determination of covalently 
bound flavin [20], SDS-polyacrylamide gel elec- 
trophoresis, and autoradiography were as de- 
scribed 1211. 
3. RESULTS AND DIS~~SSIUN 
3.1. ~-~~r~~~~~ structure if Fp, @ and 
~yt~~~r~rn~ 
f3H]Phe-labelled B. subtilis SDH-cytochrome 
b-S58 complex was isolated from Triton 
X-100”solubilized membranes by immunoprecipi- 
tation using anti-Fp antiserum. The precipitate 
contained equimolar amounts of Fp, Ip and 
cytochrome b-558 polypeptides apart from im- 
munoglobulins, and was free from other radioac- 
tive bacterial proteins (fig.lA). The immuno- 
precipitate was mixed with a 30-fold excess of 
apomyoglobin (10 nmol) added as carrier and in- 
ternal standard and was submitted to radio- 
sequence analysis. The results are shown in fig.2. 
The immunoglobulin chains did not interfere with 
the analysis. 
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Fig.1. [3H]Phe-labelled SDH-cytochrome b-558 
complex (A) and [35S]Met-labelled Fp from E. coli 
(pSH1047) (B, lane 1) and from B. subtilis KA97123 (B, 
lane 2) immunoprecipitated with anti-Fp antiserum and 
analyzed by SDS-polyacrylamide gel electrophoresis 
(lo-15% gradient gel in A and 12% uniform gel in B). 
Autoradiographs (fluorograph in A) are shown. Fp, Ip, 
and cytochrome b-558 contain 20, 9 and 20 Phe residues 
per polypeptide, respectively [8,9]. The bands seen at a 
molecular mass smaller than 65 kDa in panel B are 
breakdown fragments of Fp. 
Major peaks of 3H were obtained in cycles 8, 25, 
and 3 1 (derived from Ip + cytochrome, Ip, and Fp, 
respectively, as shown in fig.3), minor peaks in 
cycles 7 and 24 (both from shorter forms of 
cytochrome, cf. fig.3). To resolve the overlapping 
degradation patterns, each radioactive subunit was 
separately electroblotted from a gel after 
preparative SDS-polyacrylamide electrophoresis, 
after which apomyoglobin was added. The results 
of degradation of the filter-immobilized proteins 
are shown in fig.4. Ip contained the first ‘H- 
labelled Phe at position 8 in agreement with the 
results obtained from analysis of the whole com- 
plex. Cytochrome b-558 contained 3H-labelled Phe 
at positions 6, 7, 8, 9, 23 and 24. These results also 
agree with those in fig.2 and indicate the presence 
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Fig.2. N-terminal radiosequence analysis of [3H]Phe- 
labelled SDH-cytochrome complex isolated from B. 
subtifis membranes. The N-terminal amino acid 
sequence of each polypeptide as deduced from the DNA 
sequence and the radiosequence analysis of the proteins 
is shown in fig.3. 
of a ragged N-terminus derived from the 
presence/absence of one residue. Thus, the 
cytochrome isolated from the membrane-bound 
functional complex apparently has two forms in 
different amounts (fig.3). Similar microhetero- 
geneities have been found in other proteins [22]. 
We conclude from the N-terminal analysis of 
[3H]Phe-labelled subunits that: (i) the open reading 
frame and the initiation of translation predicted 
from the DNA sequence are correct for all three 
polypeptides; and that (ii) the Met coded for by the 
AUG initiation codon has been removed from the 
native Fp and Ip, and non-stoichiometrically (to 
about 50’?‘0) from the native cytochrome b-558 
polypeptides (fig.3). 
It is unknown by what mechanism the 
cytochrome b-558 is inserted across the 
cytoplasmic membrane. The degradation data in 
relation to the DNA sequence show that the pro- 
tein is not translated as a larger precursor with an 
N-terminal extension which is cleaved off upon in- 
tegration into the membrane. The lack of a larger 
precursor is also supported by the observation that 
the original N-terminal sequence deduced from the 
DNA lacks the characteristics of a leader sequence 
[8]. The molecular mass of the cytochrome b-558 
polypeptide as estimated from SDS-polyacryl- 
amide gel electrophoresis and as calculated from 
the nucleotide sequence [8] differs by 4 kDa, but 
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Fig.3. N-terminal amino acid sequence of B. subtilis Fp, 
Ip, and cytochrome b-558 polypeptides. The structures 
are as determined by DNA sequence analysis and the 
starting points as established from the radiosequence 
analysis (Phe (F) labelled is underlined). Two forms of 
cytochrome b-558 polypeptide were found. 
this is likely to be within the accuracy of the 
estimate from electrophoresis (cf. [23,24]). 
3.2. B. subtilis Fp expressed in E. coli is defective 
The three polypeptides of the B. subtilis 
SDH-cytochrome b-558 complex are expressed 
from plasmid pSH1047 in E. coli, but the func- 
tional complex is not assembled [9]. Fp and Ip are 
found in the cytoplasm, whereas cytochrome b-558 
with normal physico-chemical properties is found 
in the inner membrane. Significantly, active 
membrane-bound SDH complex is expressed from 
pS1047 in B. subtilis [12]. These facts demonstrate 
that the sdhCAB operon in pSH1047 is intact and 
suggest hat an answer to why the complex is not 
formed in E. coli (pSH1047) is to be found in dif- 
ferences in translational/post-translational pro- 
cessing of the SDH subunits in the two bacteria. 
A slightly faster electrophoretic mobility of B. 
subtilis Fp synthesized in E. coli compared to that 
of B. subtilis indicated a defect ([9] and fig.lB). 
The Fp in B. subtilis undergoes at least two post- 
translational modifications before assembly into 
the SDH complex; the N-terminal Met is removed 
(this work) and the His at position 40 is 
flavinylated [25]. To determine if these two 
modifications also occur in E. coli we isolated 
[35S]Met-labelled Fp by immunoprecipitation from 
E. coli MVlOCh3/86(pSH1047) and as a control 
from B. subtilis mutant KA97123. This mutant 
lacks Ip subunits and therefore accumulates 
flavinylated and reconstitutively active Fp in the 
cytoplasm [21]. Each immunoprecipitated protein 
(fig.lB) was analyzed for covalently bound flavin 
and for amino acid sequence by 30 cycles of 
radiosequence degradation. 
The B. subtilis Fp from both E. coli and B. sub- 
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Fig.4. N-terminal radiosequence analysis of isolated and 
electroblotted [3H]Phe-labelled Ip (top panel) and 
cytochrome b-558 (bottom panel) polypeptides from B. 
subtifis SDH complex. 
tilis has the first [35S]Met at position 16 and the 
second at 26 (not shown). These results comple- 
ment and confirm the [3H]Phe sequence data 
(fig.3). Furthermore, they show that the Fp from 
the two bacteria is processed identically at the N- 
terminus which contains the&$ fold [9,26] impor- 
tant for FAD-protein interaction. 
The content of covalently bound flavin in the Fp 
isolated from E. coli (pSH1047) was less than 
15070, i.e. not detectable, compared to that of Fp 
synthesized in B. subtilis (table 1). This deficiency 
does not seem to result from a general disturbance 
of the flavinylating machinery in the E. coli cell. 
Membranes from E. coli (pSH1047) and from cells 
containing the plasmid vector without sdh DNA 
have approximately the same amount of 
membrane-bound SDH activity 191. Thus, the 
biosynthesis of homologous SDH in E. coli is not 
affected by the simultaneous synthesis of relatively 
large amounts of B. subtilis SDH protein. Further- 
more, fumarate reductase amplified 30-40-fold in 
aerobically grown E. coli is fully flavinylated [27]. 
Volume 213, number 2, FEBS LETTERS March 1987 
Table 1 
Flavin content in B. subtilis [35S]Met-labelled Fp isolated 
by immunoprecipitation from the soluble cell fraction of 
B, subtilis and E. coli strains 
Source of Fp antigen Covalently bound flavin/ 
Fp antigen 
Determined Estimated 
(nmol/cpm (nmol/mg 
x lo-6)a protein)b 
B. subtilis KA97123 1.2 5.7 
E. coli MVCh3/86(pSH1047) <0.2 <0.8 
a The specific activity in Fp from B. subtilis and E. coli 
was approximately the same as judged from 
autoradiographs of crossed immunoelectrophoresis 
plates containing identical amounts of antigen 
b “S content per protein precipitable with trichloroacetic 
acid from the B. subtilis and E. coli soluble cell 
fractions was identical. Fp antigen in the 
immunoprecipitates was calculated assuming 
4.1 mol% Met in both Fp and the average soluble 
bacterial protein 
SDH and fumarate reductase are very similar and 
contain the same prosthetic groups [2]. 
The factors needed for the covalent attachment 
of FAD to Fp in B. subtilis are unknown. Ip or 
cytochrome b-558 subunits are not involved, and 
mutations affecting the flavinylation have only 
been found within the structural gene for Fp 
[21,25]. Folding of apo-Fp seems necessary before 
the cofactor can be bound; e.g. the N-terminal 150 
amino acid residues are not sufficient for the 
flavinylation of His-40 to occur, and different 
amino acid substitutions far downstream from 
residue 100 can prevent the covalent modification 
1251. 
The flavin deficiency in B. subtilis Fp expressed 
in E. co/i together with a normal assembly of E. 
coli SDH suggest that host-specific factors can 
either be required for or prevent the flavinylation. 
This is in contrast to what has been found for Ar- 
throbacter oxidans 6-hydroxy-D-nicotine oxidase 
which also contains ga-N(3)His-bound FAD. The 
A. oxidans enzyme expressed in E. coli in vivo and 
in vitro is flavinylated and functional [28]. On the 
other hand, attempts to flavinylate E. coli 
fumarate reductase in vitro have been reported to 
be unsuccessful [29]. 
The B. subtilis apo-Fps synthesized in E. coli 
and B. subtilis, respectively, are possibly not struc- 
turally identical although the N-termini are the 
same. This could cause the flavin defect and is in- 
dicated by three independent observations. First, 
the increased electrophoretic mobility of Fp 
isolated from E. coli is not unambiguously explain- 
ed by the absence of flavin. Different B. subtilis 
mutant Fp subunits which lack flavin as a result of 
single amino acid substitutions co-migrate or 
migrate slower than the wild-type subunit ([21] and 
Hederstedt, unpublished). Second, the SDH- 
cytochrome b-558 complex with a full complement 
of iron-sulfur centers can be assembled in B. sub- 
tilis without the flavin [25,30]. Third, the iron- 
sulfur center S-l is not detectable in the B. subtilis 
SDH protein present in E. coli (pSH1047) cell 
lysates (Andersson and Hederstedt, preliminary 
EPR data). Similarly, mutants of B. subtilis 
mutated in Fp such that SDH is not assembled also 
lack flavin in Fp as well as center S-l [21,30]. 
Our finding that B. subtilis Fp synthesized in E. 
coli lacks the prosthetic group has important im- 
plications for research aimed at identifying factors 
needed for the covalent attachment of flavin to 
proteins. The apo-Fp made in E. coli can be pro- 
duced in large quantities and used as substrate in 
in vitro studies of flavinylation. Furthermore, if a 
single B. subtilis gene product is required for the 
modification it would be possible to clone that 
gene in E. coli (pSH1047) by selecting for B. sub- 
tilis SDH activity in an E. coli SDH negative 
background. Alternatively, if an E. coli gene 
product prevents the flavinylation it may be possi- 
ble to isolate mutants defective in that product. 
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